Fostair 100/6 is a combination inhaler used to manage and prevent symptoms of asthma and COPD. It contains two active ingredients: beclometasone dipropionate, an anti-inflammatory corticosteroid, and formoterol fumarate, a long-acting bronchodilator. This dual-action formula helps reduce airway inflammation and improves airflow, making it easier to breathe.
How It Works
Beclometasone reduces inflammation in the lungs, helping to prevent asthma attacks and flare-ups. Formoterol works by relaxing the muscles around the airways, widening them and making breathing easier. When used regularly, Fostair helps maintain symptom control. In specific asthma treatment plans like Maintenance and Reliever Therapy (MART), Fostair may also be used to relieve symptoms as they occur, offering flexibility and convenience.
Why Choose Fostair 100/6 Inhaler
Fostair offers two-in-one management with proven effectiveness for asthma and COPD. It simplifies treatment by combining a preventer and reliever into one inhaler. Its fine-particle formulation allows deep lung penetration, ensuring optimal delivery of medication. Fostair is available in a standard pMDI as well as the NEXThaler device, which is breath-actuated—ideal for those who have difficulty coordinating inhalation. It reduces the need for multiple inhalers and is supported by a strong safety and efficacy profile.
Important Note
Fostair should be used exactly as prescribed. It is not suitable for immediate, emergency relief unless advised by your doctor under a MART plan. Rinse your mouth after use to reduce the risk of oral thrush. Overuse or incorrect use may result in side effects such as tremors, palpitations, or hoarseness. Regular review is essential to ensure continued effectiveness and safety of therapy.
